Abstract
As biomedical technology has expanded, the quantity of resources has increased, and scarce resources have become scarcer. Expensive equipment, medicine, artificial organs, blood for the treatment of hemophilia, donors for organ transplant operations, and research facilities are all in limited supply. Often when research presents us with a new technology, we find ourselves uncertain whether to fund its application and, if so, how extensively to produce it. One problem is economic: how are these resources to be most efficiently provided? How can more people be helped, and how can costs be reduced? Other problems are ethical: by what principles, procedures, and policies can justice in the production and distribution of resources best be ensured? There is thus both an economic dimension and an ethical dimension to these problems, which I shall refer to, in general, as problems of macro-allocation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Beauchamp, D. E.: 1976, ‘Alcoholism as Blaming the Alcoholic’, International Journal of Addictions 11, 41–52.
Beauchamp, D. E.: 1976, ‘Public Health as Social Justice’, Inquiry 19, 3–14.
Coates, J.: 1974, ‘Some Methods and Techniques for Comprehensive Impact Assessments’, Technological Forecasting and Social Change 6, 341–357.
DHEW: 1973, The Totally Implantable Heart: A Report of the National Heart and Lung Institute, DHEW Publication No. ( NIH ) 74–91.
Eckstein, O.: 1961, ‘A Survey of the Theory of Public Expenditures Criteria’, Public Finances, Princeton University Press, Princeton, New Jersey.
Fenn, S.: 1974, ‘Dilemmas for the Regulator’, in P. Sethi (ed.), The Unstable Ground: Corporate Social Policy in a Dynamic Society, Melville, Los Angeles, pp. 191–203.
Klarman, H. E.: 1965, ‘Syphilis Control Programs’, in R. Dorfman (ed.), Measuring Benefits of Governmental Investments, Brookings Institution, Washington, D.C., pp. 367–410.
Kohlmeier, L.: 1974, ‘Effective Regulation in the Public Interest’, in P. Sethi (ed.), The Unstable Ground: Corporate Social Policy in a Dynamic Society, Melville, Los Angeles, pp. 181–190.
Maclntyre, A.: 1977, ‘Utilitarianism and Cost-Benefit Analysis: An Essay on the Relevance of Moral Philosophy to Bureaucratic Theory’, in K. Sayre (ed.), Values in the Electric Power Industry, University of Notre Dame Press, South Bend, Ind., pp. 217–237.
Rawls, J.: 1971, A Theory of Justice, Harvard University Press, Cambridge, Mass.
Rawls, J.: 1977, ‘The Basic Structure as Subject’, American Philosophical Quarterly 14, 159–165.
Veatch, R. M.: 1976, ‘What is a “Just” Health Care Delivery’, in R. M. Veatch and R. Branson (eds.), Ethics and Health Policy, Ballinger, Cambridge, pp. 127–153.
Wilson, R. (testimony): in re Proposed Standards for Occupational Exposure to Benzene, OSHA Docket No. #-059.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 D. Reidel Publishing Company
About this chapter
Cite this chapter
Beauchamp, T.L. (1982). Morality and the Social Control of Biomedical Technology. In: Bondeson, W.B., Tristram Engelhardt, H., Spicker, S.F., White, J.M. (eds) New Knowledge in the Biomedical Sciences. Philosophy and Medicine, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7723-5_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-7723-5_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7725-9
Online ISBN: 978-94-009-7723-5
eBook Packages: Springer Book Archive